title: Examining product risk in context: the case of zomepirac.
authors: B U
authors: BU
authors: Musa
mesh_terms: D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects*; D017277:Drug Approval; D006801:Humans; D011358:Product Surveillance, Postmarketing; D014046:Tolmetin / Q000009:adverse effects / Q000031:analogs & derivatives*
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; C020549:zomepirac; D014046:Tolmetin